Department of Health Undersecretary and NVOC Chairperson Dr. Myrna Cabotaje, in a virtual meeting on May 6, also reiterated the finalization of the Priority A1 (Frontline Health Workers), A2 (Senior Citizens) and A3 (adults with co – morbidities) master lists that will be the basis of allocation of Coronavirus disease (COVID – 19) vaccines.
Based on NVOC data, aside from the 15,000 doses of Sputnik V that arrived last May 1 and the 1.5 million doses of Sinovac delivered on May 6, the country expects the delivery of more than 4 million doses of COVID – 19 vaccines this May. There are also 2,030,400 doses of AstraZeneca and 193,050 doses of Pfizer vaccines from the COVAX Facility.
For the month of June, the NVOC expects around 9 to 10 million doses of COVID – 19 vaccines that include Moderna, Sinovac, Sputnik V, AstraZeneca and Pfizer.
Cabotaje bared that new allocation will be sectoral or based on masterlisted and estimated eligible population, geographic or based on the burden of disease, capacity for handling and storing the vaccines and rate of consumption.
On the national vaccination program, as of May 6 NVOC data, a total of 2,226,973 doses of COVID – 19 vaccines have been administered, of which 1,854,959 eligible population were vaccinated with their first dose and 372,014 eligible population received their complete doses of COVID – 19 vaccines.
In the Cordillera, the RVOC reported that as of May 6, 45,816 frontline health care workers, senior citizens and adults with co – morbidities were vaccinated with their first dose while 15,404 of them already completed their two doses of Sinovac vaccine.
In terms of the allocated vaccines, of the 48,100 Sinovac doses, 44,816 or 93.38 were already vaccinated for the first dose of eligible population in Priority Groups A1, A2 and A3, while the 10,000 doses of AstraZeneca were all used to vaccinate (first dose) of eligible population in priority A1 or frontline health workers.
Meanwhile, Cabotaje shared that AstraZeneca will resume its use for 18 years old and above and the NVOC will soon issue the related guidelines.
She also reminded RVOCs that COVAX delivered COVID – 19 vaccines are solely for the use of eligible population in priority groups A1, A2 and A3. (JDP/CCD-PIA CAR)
By Carlito C. Dar